NASDAQ:BCDA

Biocardia Stock Predictions

etoro logo Buy BCDA
*Your capital is at risk
$0.87
-0.0256 (-2.84%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BCDA Prediction Chart

BCDA Predictions History

Latest community submissions for BCDA.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 22, 2025 $1.22 +5.32% $1.11 X 89.94% 0
Sep 22, 2025 $1.20 +3.32% $1.11 X 92.02% 0
Sep 22, 2025 Bearish $1.11 V 1
Jul 7, 2025 $2.04 -3.89% $2.10 V 97.03% 0
Jul 7, 2025 $2.14 +0.90% $2.10 X 98.14% 0
ratraceg ratraceg @ratraceg.20228
Jul 7, 2025 $2.94 +38.68% $2.10 X 60.00% 0
May 1, 2025 $3.04 -3.04% $2.85 V 93.17% 1
May 1, 2025 $3.08 -1.90% $2.85 V 91.92% 1
May 1, 2025 Bullish $2.85 X 0
Mar 5, 2025 $2.42 -3.99% $2.54 X 95.25% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BCDA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOCARDIA, INC.
BioCardia
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE